Moderna CEO Announces New mRNA Shot to Treat Heart Failure Patients

Pharmaceutical company behind the harmful COVID mRNA jab found to cause significant heart issues are now developing a vaccine to treat heart issues.

Image Credits: screenshot/YouTube.

Moderna has developed a new mRNA shot meant to treat patients who suffered heart failure, according to CEO Stéphane Bancel.

Speaking to the Business Weekend podcast on Sky News in October that is now recirculating social media, Bancel boasted of a new experimental program where patients’ hearts are injected with mRNA.

“We are now in a super exciting program where we inject mRNA in people’s heart after a heart attack to grow back new blood vessels and re-vascularize the heart,” Bancel said. “It’s like science fiction medicine.”

The Sky News reporter pointed out Moderna’s research investments were only made possible due to massive profits it made from the COVID-19 mRNA vaccine.

“That’s the irony of COVID, is it really has in some ways allowed you to go and develop these other areas because of the revenues that came through the door,” he said.

Bancel replied, “You’re 100% right.”

A business update from Moderna released Monday outlining several mRNA projects details the mRNA technology behind its new heart attack vaccine.

From a Moderna’s recent business update:

mRNA-0184 encodes for relaxin, a naturally occurring hormone that is known to cause hemodynamic changes that are potentially beneficial for heart failure patients. The mRNA sequence of mRNA-0184 is engineered to instruct the body to produce relaxin with an extended half-life, with the goal of producing a sustained clinical benefit in heart failure patients – this longer half-life may result in more durable effects compared to previous approaches.

A deeper irony of Moderna’s heart attack vaccine research is the very COVID-19 vaccine it developed and profited from has been discovered to cause major heart issues like myocarditis and pericarditis.

A Swiss study found the COVID mRNA shots injured the hearts of ALL its recipients, with 2.8% having levels associated with subclinical myocarditis.

Reports of cardiovascular adverse reactions from the COVID jabs are so prevalent that both Moderna and Pfizer announced in November they will investigate and study long-term risks of myocarditis in patients who took the COVID shots.

Pfizer even partnered with a company in 2021 to develop heart medication meant to treat heart conditions brought on by the mRNA shot.

In sum, Moderna released a product that causes major heart problems, then used the profits from that product to develop a vaccine that treats those same heart problems.

Absolutely diabolical.

Watch the full interview:


Twitter: @WhiteIsTheFury

Truth Social: @WhiteIsTheFury

Gettr: @WhiteIsTheFury

Gab: @WhiteIsTheFury

Minds: @WhiteIsTheFury

Parler: @WhiteIsTheFury



WATCH ALL SHOWS

AUDIO